Free Float 103,14 %
Shares Float 1,44 B
Shares Outstanding 1,39 B
DIAGONAL BIO AB
Share · SE0015961826 · A3CR6X (XSTO)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of DIAGONAL BIO AB
No Price
Share Float & Liquidity
Company Profile for DIAGONAL BIO AB Share
Diagonal Bio AB operates as a biotechnology company in Sweden. It is involved in developing the Panviral platform for detecting and diagnosing small sections of pathogen genomes, such as viruses, bacteria, and fungi. The company was founded in 2020 and is headquartered in Lund, Sweden.
Company Data
Name DIAGONAL BIO AB
Company Diagonal Bio AB (publ)
Website
https://diagonalbio.com
Primary Exchange 
Frankfurt
Frankfurt
WKN A3CR6X
ISIN SE0015961826
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Karin Wehlin MBA
Market Capitalization 20 Mio
Country Sweden
Currency EUR
Employees 0,0 T
Address The Spark, 223 81 Lund
IPO Date 2021-07-16
Stock Splits
| Date | Split |
|---|---|
| 25.11.2022 | 175:103 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ STOCKHOLM AB | DIABIO.ST |
| Frankfurt | 9F1.F |
More Shares
Investors who hold DIAGONAL BIO AB also have the following shares in their portfolio:
